
Wonride M 1mg/500mg Tablet SR
Marketer
Wonset Healthcare Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Wonride M 1mg/500mg Tablet SR
DiabetaComb 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer DiabetaComb with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with well-controlled blood sugar; discontinuation without medical guidance risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. DiabetaComb is one component of a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Maintain regular mealtimes and carry a quick-acting glucose source (e.g., sugary snacks or juice). Alcohol increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. DiabetaComb is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before use. Pregnant or lactating women require medical consultation prior to initiating treatment. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.
Primary Ingredients of Wonride M 1mg/500mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Wonride M 1mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Wonride M 1mg/500mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Wonride M 1mg/500mg Extended-Release Tablet with a meal.
Common Side effects of Wonride M 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Wonride M 1mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or breaking it. The Wonride M 1mg/500mg Sustained-Release tablet should be taken with a meal.
How Wonride M 1mg/500mg Tablet SR works:
Each Wonride M 1mg/500mg sustained-release tablet combines glimepiride (a sulfonylurea) and metformin (a biguanide) to manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Wonride M 1mg/500mg Tablet SR with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Wonride M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Prolonged-release Wonride M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from the medication.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience such symptoms.
KidneyCAUTION
Patients with kidney impairment should use Wonride M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Wonride M 1mg/500mg SR tablets. Medical supervision, including regular kidney function assessments, is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should use Wonride M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, a low initial dose is typically recommended, while use is discouraged in patients with severe hepatic dysfunction.
What if you forget to take Wonride M 1mg/500mg Tablet SR :
Should you forget a dose of Wonride M 1mg/500mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Wonride M 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
